Linked Life Data

9551770

Source:http://linkedlifedata.com/resource/pubmed/id/9551770

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9551770rdf:typepubmed:Citationlld:pubmed
pubmed-article:9551770lifeskim:mentionsumls-concept:C0009170lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0024400lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0041177lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0030605lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:9551770lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:9551770pubmed:issue2lld:pubmed
pubmed-article:9551770pubmed:dateCreated1998-6-18lld:pubmed
pubmed-article:9551770pubmed:abstractText2Beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) is a cocaine analog which has been shown in rhesus monkeys to have cocaine-like discriminative stimulus effects and a long duration of action (>8 h), yet does not function as a reinforcer when substituted for cocaine in monkeys responding under a fixed-interval 5-min schedule (Nader et al. 1997). The purpose of the present study was to evaluate the reinforcing effects of PTT under a fixed-ratio (FR) schedule and to determine if decreasing the inter-injection interval would influence the reinforcing effects of PTT. Male rhesus monkeys (n=3) were trained to respond under a multiple FR 30 food-drug-food schedule. When responding was stable, cocaine (0.003-0.3 mg/kg per injection) or PTT (0.001-0.03 mg/kg per injection) was available during the drug component for at least five consecutive sessions and until stable responding was observed. To investigate whether the inter-injection interval would influence PTT-maintained response rates, the time-out (TO) following PTT injections was reduced from 180 or 300 s to 10 s for at least five consecutive sessions. Cocaine-maintained response rates were characterized as an inverted-U shaped function of dose, with peak rates maintained by 0.03 mg/kg per injection cocaine. PTT (0.001-0.03 mg/kg per injection) maintained response rates significantly higher than rates maintained by the PTT vehicle, but significantly lower than cocaine-maintained response rates; PTT intake increased with a dose. A reduction of the TO following PTT injections to 10 s did not alter PTT-maintained response rates or total session intake. Self-administered PTT was more potent than cocaine at decreasing food-maintained responding. These results suggest that for long-acting compounds like PTT, reinforcing effects are more likely to be observed when the drug is available under a ratio-based schedule, compared to an interval-based schedule.lld:pubmed
pubmed-article:9551770pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9551770pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9551770pubmed:languageenglld:pubmed
pubmed-article:9551770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9551770pubmed:citationSubsetIMlld:pubmed
pubmed-article:9551770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9551770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9551770pubmed:statusMEDLINElld:pubmed
pubmed-article:9551770pubmed:monthMarlld:pubmed
pubmed-article:9551770pubmed:issn0033-3158lld:pubmed
pubmed-article:9551770pubmed:authorpubmed-author:GrantK AKAlld:pubmed
pubmed-article:9551770pubmed:authorpubmed-author:NaderM AMAlld:pubmed
pubmed-article:9551770pubmed:authorpubmed-author:DaviesH MHMlld:pubmed
pubmed-article:9551770pubmed:authorpubmed-author:NaderS HSHlld:pubmed
pubmed-article:9551770pubmed:authorpubmed-author:BirminghamA...lld:pubmed
pubmed-article:9551770pubmed:issnTypePrintlld:pubmed
pubmed-article:9551770pubmed:volume136lld:pubmed
pubmed-article:9551770pubmed:ownerNLMlld:pubmed
pubmed-article:9551770pubmed:authorsCompleteYlld:pubmed
pubmed-article:9551770pubmed:pagination139-47lld:pubmed
pubmed-article:9551770pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9551770pubmed:meshHeadingpubmed-meshheading:9551770-...lld:pubmed
pubmed-article:9551770pubmed:meshHeadingpubmed-meshheading:9551770-...lld:pubmed
pubmed-article:9551770pubmed:meshHeadingpubmed-meshheading:9551770-...lld:pubmed
pubmed-article:9551770pubmed:meshHeadingpubmed-meshheading:9551770-...lld:pubmed
pubmed-article:9551770pubmed:meshHeadingpubmed-meshheading:9551770-...lld:pubmed
pubmed-article:9551770pubmed:meshHeadingpubmed-meshheading:9551770-...lld:pubmed
pubmed-article:9551770pubmed:year1998lld:pubmed
pubmed-article:9551770pubmed:articleTitleFurther evaluation of the reinforcing effects of the novel cocaine analog 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) in rhesus monkeys.lld:pubmed
pubmed-article:9551770pubmed:affiliationCenter for the Neurobiological Investigation of Drug Abuse, Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1083, USA.lld:pubmed
pubmed-article:9551770pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9551770pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9551770pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9551770lld:pubmed